OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $221.9 million versus the consensus estimate of $245.3 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.